Biotech Values

[urche]

MYRX-JAV merger

I can't think of another takeover deal that fostered so little interest, and the little sentiment seems to be all negative from both sides of the marriage.

Since the announcement on Dec 18, JAV is up a few percent, Myriad is down about 8%, almost no enthusiasm for the deal on respective Ihub boards---and already a law firm is threatening to sue Javelin for "the potential unfairness of the price to Javelin shareholders and the process by which the Company’s Board of Directors considered and approved the transaction". This seems to be a deal that leaves no one happy.

I admit to having had a much higher perception of the value of Javelin's pipeline.

Burned again,
Urche